Nonspecific activation of macrophages for antitumor immunity.
D000818:Animals; D001202:Ascitic Fluid / Q000166:cytology; D004334:Drug Administration Schedule; D005260:Female; D005622:Friend murine leukemia virus; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy; D004915:Leukemia, Erythroblastic, Acute / Q000276:immunology; D007942:Leukemia, Experimental / Q000276:immunology*; D008264:Macrophages / Q000187:drug effects / Q000201:enzymology / Q000276:immunology*; D051379:Mice; D008815:Mice, Inbred Strains; D010544:Peroxidases / Q000378:metabolism; D013154:Spleen / Q000276:immunology / Q000382:microbiology; D013163:Splenomegaly / Q000517:prevention & control; D013864:Thioglycolates / Q000008:administration & dosage / Q000494:pharmacology*
D013864:Thioglycolates; D005954:Glucosephosphate Dehydrogenase; D010544:Peroxidases